The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: Insights from a large-scale multicenter study.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Onishi Naoaki, Kaitani Kazuaki, Nakagawa Yoshihisa, Inoue Koichi, Kobori Atsushi, Nakazawa Yuko, Ozawa Tomoya, Kurotobi Toshiya, Morishima Itsuro, Miura Fumiharu, Watanabe Tetsuya, Masuda Masaharu, Naito Masaki, Fujimoto Hajime, Nishida Taku, Furukawa Yoshio, Shirayama Takeshi, Tanaka Mariko, Okajima Katsunori, Yao Takenori, Egami Yasuyuki, Satomi Kazuhiro, Noda Takashi, Miyamoto Koji, Haruna Tetsuya, Higashi Yukei, Ito Makoto, Horie Minoru, Kusano Kengo F, Shimizu Wataru, Kamakura Shiro, Shimizu Yukiko, Hanazawa Koji, Tamura Toshihiro, Izumi Chisato, Morimoto Takeshi, Kimura Takeshi, Shizuta Satoshi, EAST-AF Investigators
Аннотация
METHODS: The Efficacy of Short-Term Use of Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation trial followed 2038 patients who underwent radiofrequency catheter ablation for atrial fibrillation.
RESULTS: Of the patients, 907 (45%) had early recurrences within 90 days after the initial ablation. We divided these patients into two groups according to the timing of the first early recurrence episode, namely the ER1 group (early recurrence during the early phase; 0-30 days, n = 814) and ER2 group (early recurrence during the late phase; 31-90 days, n = 93). Three years after ablation, patients with early recurrences had a significantly lower event-free rate from late recurrences after a 90-day blanking period than patients without early recurrences (36.2% and 74.2%, respectively; log-rank, P < 0.0001). Three years after ablation, the event-free rate was significantly higher in the ER1 than the ER2 group (38.3% and 17.1%, respectively; log-rank, P < 0.0001). Moreover, the event-free rate at 3 years in the ER2 group was extremely low (5.6%) in patient with non-paroxysmal atrial fibrillation.
CONCLUSION: Early recurrences were strongly associated with late recurrences, especially in patients with the first recurrence episode at >1 month within the blanking period after a single ablation procedure. Therefore, these patients should undergo close observation during follow-up, when they had especially with non-paroxysmal atrial fibrillation.